Atherosclerosis |
HNG |
prevents CD36 and LOX-1 upregulation; upregulates the expression of ABCA1 and ABCG1
|
[34] |
suppress LOX-1 expression |
[35] |
promotes autophagic degradation of Ox-LDL throughout lysosomal enzyme cathepsin D and its receptor FPRL1 |
[36] |
NH |
induces the expression of KLF2;inhibits the high glucose-induced secretion of TNF-α and IL-1β; reduces the expression of VCAM-1 and E-selectin
|
[39] |
MOTS-c |
decreases the expression levels of the AT-1 and ET-B receptors; increased the level of phosphorylated AMPK |
[40] |
Ageing |
MOTS-c and HN |
increase secretion of SASP components and rise mitochondrial respiration |
[46] |
stimulate the secretion of SASP components (cytokines IL-1β, IL-6, IL-8, IL-10 and TNF-α) |
[8] |
Insulin resistance |
HN |
increases insulin sensitivity in muscles and the liver; increase fatty acid metabolism signalling and insulin-mediated AKT-signalling |
[51,52] |
HNG |
improves insulin sensitivity in the brain through the regulation of IRS-1/mTOR signalling pathway in the hippocampus |
[53] |
SHLP2 and SHLP3 |
enhance 3T3-L1 pre-adipocyte differentiation |
[4] |
SHLP2 |
SHLP2 increased glucose uptake and suppressed hepatic glucose production |
[4] |
MOTS-c |
increases fatty acids β-oxidation and mitochondria biogenesis; stimulates GLUT4 expression |
[54,55] |
Hyperlipidaemia |
HN |
decreases lipid accumulation and down-regulates lipogenesis genes (SREBP1, FAS and SCD1); enhances AMPK phosphorylation-mediated effect on IR; suppresses phosphorylation of the mTOR signalling pathway |
[56] |
HNG |
decreases liver triglyceride accumulation, visceral fat and body weight gain in high-fat diet-fed mice |
[58] |
HNG and SHLP2 |
acting via the glutathione and sphingolipid metabolism pathways alter the concentrations of amino acid and lipid metabolites in plasma |
[59] |
MOTS-c |
increases AICAR levels and activates AMPK |
[3] |
activates AMPK, GLUT4 and AC; stimulating mitochondria biogenesis and increasing the level of fatty acid β-oxidation |
[60] |
improves mitochondria dynamics |
[61] |
regulates expression of ARE and NFE2L2/NRF2 |
[21] |